45 g polvo para solución oral.

A Phase I, Single-Centre, Double-Blind, Randomized, Placebo-Controlled Clinical Trial To Determine Urinary Xylose Cut-Off Point For The Diagnosis Of Hypolactasia, After A Single Dose Of Gaxilose in Children Between 5 – 11 Years Of Age.

Post-authorization phase IV low-intervention study to evaluate the efficacy under real-world conditions of the use of LacTEST 0.45 g for the diagnosis of hypolactasia in children aged 5 to 11 years presenting symptoms of lactose intolerance.

Clinical trial to evaluate the correlation between variation in intestinal lactase activity measured with LacTEST 0.45g and alteration of intestinal barrier integrity and/or intestinal permeability in patients with celiac disease